Study: Low Birth Defect Risk From Newer Epilepsy Drugs
Study: Low Birth Defect Risk From Newer Epilepsy Drugs Researchers Say Findings Are Reassuring, but Data on Topamax Inconclusive WebMD Medical News By Salynn Boyles Reviewed by Laura J. Martin,...
Click here to read the full story.
The content has been reported and it will be reviewed by a moderator.